OptiNose’s (OPTN) Neutral Rating Reiterated at Piper Sandler
Piper Sandler restated their neutral rating on shares of OptiNose (NASDAQ:OPTN – Free Report) in a report issued on Friday,Benzinga reports. Piper Sandler currently has a $9.00 price objective on the stock, down from their prior price objective of $15.00. OPTN has been the topic of a number of other research reports. HC Wainwright reissued […]
